Please provide your email address to receive an email when new articles are posted on . Visual acuity and motor coordination significantly improved after 6 months of using AmblyoPlay. The treatment ...

Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...

Please provide your email address to receive an email when new articles are posted on . Wellness company HealthyCell has announced the launch of Eye Health, the newest supplement in the company’s ...

A single injection of a gene therapy was well tolerated and showed the potential to control exudation in patients with neovascular age-related macular degeneration (wet AMD). A single subretinal dose ...

Impaired vision and blindness are common. About 3.4 million people in the US are blind or visually impaired. Vision is usually measured by visual acuity charts, and normal vision is expressed as 20/20 ...

Mean vision gains of +9 letters among patients with extensive coverage of OpRegen cell therapy to the Geographic Atrophy (GA) lesion site Evidence of retinal structural improvement persisted out to 3 ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Longer-term ...

Best corrected visual acuity improved 9.8 letters with lamivudine after 4 weeks, decreased 1.8 letters with placebo. HealthDay News — For patients with center-involved diabetic macular edema (CI-DME), ...

In eyes with diabetic macular edema, the relative efficacy of administering aflibercept monotherapy as compared with bevacizumab first with a switch to aflibercept if the eye condition does not ...